Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
AlphaRet Overnight Cream is a cosmetic skincare product developed by skinbetter science that utilizes a patented technology to combine a retinoid with an alpha hydroxy acid (specifically lactic acid). Introduced in 2016, the formulation is designed to address visible signs of skin aging, including photodamage, fine lines, wrinkles, and uneven skin tone and texture. The product works through a dual mechanism where the retinoid component increases skin cell turnover by activating retinoic acid receptors, while the lactic acid promotes exfoliation of the skin's surface. This combination is intended to provide the efficacy of traditional retinoids with significantly reduced irritation. Clinical evaluations in patients have demonstrated significant improvements in wrinkle appearance within four weeks of overnight topical application.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on AlphaRet Overnight Cream.